Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold
暂无分享,去创建一个
Jan Hansmann | Heike Walles | Sarah Nietzer | Gudrun Dandekar | Stefan Sieber | H. Walles | J. Hansmann | Stefan Sieber | M. Gasser | A. Waaga-Gasser | T. Schwarz | Thomas Schwarz | Florentin Baur | Carolin Stoffer | Heide Häfner | Martin Gasser | Ana Maria Waaga-Gasser | S. Nietzer | Gudrun Dandekar | Heide Häfner | Florentin Baur | Carolin Stoffer | Sarah Nietzer
[1] K. Schenke-Layland,et al. A human in vitro model that mimics the renal proximal tubule. , 2014, Tissue engineering. Part C, Methods.
[2] R. Knuechel,et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] H. Morreau,et al. Survival after adjuvant 5‐FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer , 2004, International journal of cancer.
[4] M. Pignatelli,et al. β-catenin - A linchpin in colorectal carcinogenesis? , 2002 .
[5] R. Ehret,et al. Isolated extracellular matrix-based three-dimensional in vitro models to study orthotopically cancer cell infiltration and invasion. , 1998, European journal of cancer.
[6] C. Unger,et al. Development and application of three-dimensional skin equivalents for the investigation of percutaneous worm invasion. , 2015, Experimental parasitology.
[7] F. Lévi,et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Jan Hansmann,et al. Engineered liver-like tissue on a capillarized matrix for applied research. , 2007, Tissue engineering.
[9] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[10] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[11] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[12] D. Albertson,et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.
[13] T. Walles,et al. Host-integration of a tissue-engineered airway patch: two-year follow-up in a single patient. , 2015, Tissue engineering. Part A.
[14] Jan Hansmann,et al. Vascularised human tissue models: a new approach for the refinement of biomedical research. , 2010, Journal of biotechnology.
[15] M. Kusunoki,et al. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. , 2001, Cancer research.
[16] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[17] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[18] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[19] M. Pignatelli,et al. Beta-catenin--a linchpin in colorectal carcinogenesis? , 2002, The American journal of pathology.
[20] Peter Friedl,et al. Tube travel: the role of proteases in individual and collective cancer cell invasion. , 2008, Cancer research.
[21] W. Bodmer,et al. 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency , 2010, British Journal of Cancer.
[22] Heike Walles,et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model , 2013, Molecular oncology.
[23] A. Lièvre,et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.
[24] H. Walles,et al. Tissue Engineering of a Human 3D in vitro Tumor Test System , 2013, Journal of visualized experiments : JoVE.
[25] P. Loehrer,et al. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. DuBois,et al. The Tumor Microenvironment in Colorectal Carcinogenesis , 2010, Cancer Microenvironment.
[27] Jinghong Xu,et al. β-catenin Overexpression in the Nucleus Predicts Progress Disease and Unfavourable Survival in Colorectal Cancer: A Meta-Analysis , 2013, PloS one.
[28] P. Friedl,et al. Classifying collective cancer cell invasion , 2012, Nature Cell Biology.
[29] Yudhijit Bhattacharjee,et al. Biomedicine. Pharma firms push for sharing of cancer trial data. , 2012, Science.
[30] C. Dai,et al. Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation , 2011, Molecular Cancer Research.
[31] Hanlin L. Wang,et al. Colorectal carcinoma: Pathologic aspects. , 2012, Journal of gastrointestinal oncology.
[32] A. Wells,et al. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas , 2008, Clinical & Experimental Metastasis.
[33] F. Braet,et al. Unlocking the ultrastructure of colorectal cancer cells in vitro using selective staining. , 2010, World journal of gastroenterology.
[34] H. Mertsching,et al. Generation and Transplantation of an Autologous Vascularized Bioartificial Human Tissue , 2009, Transplantation.
[35] Jayanta Debnath,et al. Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.
[36] R. James,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.
[37] Raghu Kalluri,et al. The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.
[38] Katja Schenke-Layland,et al. The physiological performance of a three-dimensional model that mimics the microenvironment of the small intestine. , 2011, Biomaterials.
[39] Tobias Schmelzle,et al. Engineering tumors with 3D scaffolds , 2007, Nature Methods.
[40] Nizar M. Mhaidat,et al. 5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-δ , 2014, Oncology letters.
[41] C. Köhne,et al. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[42] Claudio Domenici,et al. A novel dual‐flow bioreactor simulates increased fluorescein permeability in epithelial tissue barriers , 2014, Biotechnology journal.
[43] J. Banyard,et al. The role of EMT and MET in cancer dissemination , 2015, Connective tissue research.
[44] I. Cree,et al. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue. , 2010, Current opinion in pharmacology.
[45] A. Ostman,et al. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. , 2009, Current opinion in genetics & development.
[46] F. Innocenti,et al. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[47] E. Sahai,et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.
[48] A. Buettner,et al. Transport of hop aroma compounds across Caco-2 monolayers. , 2014, Food & function.